Skip to main content

Advertisement

Log in

High-frequency repetitive transcranial magnetic stimulation (HF-rTMS) on global cognitive function of elderly in mild to moderate Alzheimer’s disease: a systematic review and meta-analysis

  • Review Article
  • Published:
Neurological Sciences Aims and scope Submit manuscript

Abstract

Objective

High-frequency repetitive transcranial magnetic stimulation (HF-rTMS) is a non-invasive brain stimulation technique used to improve cognitive deficits in patients with Alzheimer’s disease (AD). This systematic review and meta-analysis aimed to evaluate the efficacy of HF-rTMS in improving global cognitive function rehabilitation in elderly patients with mild to moderate AD.

Methods

A detailed literature search of publications using ten databases (Chinese: Wanfang, VIP Periodical, SinoMed, the Chinese National Knowledge Infrastructure; English: PubMed, Embase, OVID, Web of Science, Cochrane Library, and EBSCOhost) was performed to identify English and Chinese language articles published up to December 2022. We only included randomized controlled trials (RCTs) that evaluate the effect of HF-rTMS on elderly patients with mild to moderate AD. The retrieved studies were carefully reviewed, extracted data, and assessed quality.

Results

Seventeen studies, including 1161 elderly patients with mild to moderate AD, were included in this meta-analysis. Compared to the control group, HF-rTMS could increase MMSE (mean difference [MD] = 3.64; 95%CI 1.86–5.42; P < 0.0001), MoCA (MD = 3.69; 95%CI 1.84–5.54; P < 0.0001), P300 amplitude (MD = 1.09; 95%CI 0.45–1.72; P = 0.0008), and total effective rate scores (MD = 3.64; 95% CI 2.14–6.18; P < 0.00001) while decreasing ADAS-Cog (MD =  − 3.53; 95%CI − 4.91– − 2.15; P < 0.00001) and P300 latency scores (MD =  − 38.32; 95%CI − 72.40– − 4.24; P = 0.03). Our study showed that HF-rTMS could improve the global cognitive function of elderly patients with mild to moderate AD.

Conclusion

HF-rTMS can improve global cognitive function in elderly patients with mild to moderate AD, which is an effective and safe rehabilitation treatment tool for AD patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

We’re sorry, something doesn't seem to be working properly.

Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10
Fig. 11

Similar content being viewed by others

References

  1. Kumar A, Sidhu J, Goyal A et al (2022) Alzheimer disease. In: StatPearls. Treasure Island (FL), StatPearls Publishing, pp 1–2

  2. Crous-Bou M, Minguillon C, Gramunt N et al (2017) Alzheimer’s disease prevention: from risk factors to early intervention. Alzheimers Res Ther 9(1):71

    Article  PubMed  PubMed Central  Google Scholar 

  3. The Alzheimer’s Association (2021) 2021 Alzheimer’s disease facts and figures. Alzheimers Dement 17(3):327–406

    Article  Google Scholar 

  4. Se TE, Fauzi A, Tang YQ et al (2021) A review on advances of treatment modalities for Alzheimer’s disease. Life Sci 276:119129

    Article  Google Scholar 

  5. Tang Y, Lutz MW, Xing Y (2019) A systems-based model of Alzheimer’s disease. Alzheimers Dement 15(1):168–171

    Article  PubMed  Google Scholar 

  6. Zilberzwige-Tal S, Gazit E (2018) Go with the flow-microfluidics approaches for amyloid research. Chem Asian J 13(22):3437–3447

    Article  CAS  PubMed  Google Scholar 

  7. Maccioni RB, Gonzalez A, Andrade V et al (2018) Alzheimer s disease in the perspective of neuroimmunology. Open Neurol J 12:50–56

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. The Alzheimer’s Association (2022) 2022 Alzheimer’s disease facts and figures. Alzheimers Dement 18(4):700–789

    Article  Google Scholar 

  9. Kropotov JD (2016) Functional neuromarkers for psychiatry. Academic Press, San Diego, pp 281–283

    Book  Google Scholar 

  10. Pulopulos MM, Allaert J, Vanderhasselt MA et al (2022) Effects of HF-rTMS over the left and right DLPFC on proactive and reactive cognitive control. Soc Cogn Affect Neurosci 17(1):109–119

    Article  PubMed  Google Scholar 

  11. Burke MJ, Fried PJ, Pascual-Leone A (2019) Transcranial magnetic stimulation: neurophysiological and clinical applications. Handb Clin Neurol 163:73–92

    Article  PubMed  Google Scholar 

  12. Wang X, Mao Z, Ling Z et al (2020) Repetitive transcranial magnetic stimulation for cognitive impairment in Alzheimer’s disease: a meta-analysis of randomized controlled trials. J Neurol 267(3):791–801

    Article  PubMed  Google Scholar 

  13. Lin Y, Jiang WJ, Shan PY et al (2019) The role of repetitive transcranial magnetic stimulation (rTMS) in the treatment of cognitive impairment in patients with Alzheimer’s disease: a systematic review and meta-analysis. J Neurol Sci 398:184–191

    Article  PubMed  Google Scholar 

  14. Wang Y, Cheng C, Shen HY et al (2021) Meta-analysis of efficacy of transcranial magnetic stimulation for the treatment of cognitive function and behavioral and psychological symptoms of dementia in patients with Alzheimer’s disease. J Shanghai Jiao Tong University (Medical Science) 41(07):931–941

    Google Scholar 

  15. Budak M, Bayraktaroglu Z, Hanoglu L (2022) The effects of repetitive transcranial magnetic stimulation and aerobic exercise on cognition, balance and functional brain networks in patients with Alzheimer's disease. Cogn Neurodyn 17(1):9–61

  16. Youichi S, Koichi H, Tomoo M et al (2022) Randomized, sham-controlled, clinical trial of repetitive transcranial magnetic stimulation for patients with Alzheimer's dementia in Japan. Front Aging Neurosci 14:993306

  17. Wang ZH, Xu YX, Liu ZP (2021) Analysis of the efficacy and safety of repeated transcranial magnetic stimulation combined with donepezil in the treatment of mild to moderate Alzheimer’s disease. Drug Evaluation 18(10):605–607

    Google Scholar 

  18. Li Jin (2021) Clinical efficacy of extract injection of ginkgo leaf combined with transcranial magnetic stimulation on Alzheimer’s disease. China Modern Doctor 59(12):43–46

    Google Scholar 

  19. Bagattini C, Zanni M, Barocco F et al (2020) Enhancing cognitive training effects in Alzheimer’s disease: rTMS as an add-on treatment. Brain Stimul 13(6):1655–1664

    Article  PubMed  Google Scholar 

  20. Wang JD, Zhou TT, Chen XQ et al (2019) Clinical effect of Quetiapine combined with cranial magnetic stimulation on psychobehaVioral symptoms of senile dementia. China Med Herald 16(17):46–49

    Google Scholar 

  21. Sun QY (2019) Observation on the treatment of Alzheimer’s disease with repetitive transcranial magnetic stimulation. J Med Aesthetice Cosmetol 28(12):29

    Google Scholar 

  22. Zhang FX (2019) The clinical application of repetitive transcranial magnetic stimulation in Alzheimer’s disease. Huazhong University of Science and Technology, Wuhan, pp 12–61

    Google Scholar 

  23. Ni L, Hua HS, Shao JF et al (2019) Effects of repetitive transcranial magnetic stimulation on cognitive function and psychological symptoms in patients with mild to moderate Alzheimer’s disease. Clin Educ Gen Pract 17(03):216–219

    Google Scholar 

  24. Zhang H, Ji RX, Li J (2019) Treating Alzheimer’s disease using transcranial magnetics stimulation. Chin J Phys Med Rehabil 01:18–22

    Google Scholar 

  25. Li L, Zhou L (2018) The effect of donepezil combined with repetitive transcranial magnetic stimulation on cognitive function and urinary AD7c-NTP levels in patients with AIzheimer’s disease. Pract J Clin Med 15(06):123–126

    Google Scholar 

  26. Zhao JW (2017) Effect of repetitive transcranial magnetic stimulation on cognitive function in patients with Alzheimer disease. Shangdong University, Jinan, pp 18–41

    Google Scholar 

  27. Liu X, Hou QM, Zhao XQ et al (2017) Therapeutic effect of repetitive transcranial magnetic stimulation (10Hz) on BPDS and executive functions in patients with mild to moderate Alzheimer Disease. J North Sichuan Med Coll 32(03):376–379

    CAS  Google Scholar 

  28. Liu YH, Wang LN, Bian YH et al (2017) Effect of repetitive transcranial magnetic stimulation with different frequency on cognitive function and behavioral and psychological symptoms in patients with senile dementia. J Int Psychiatr 44(02):263–266

    CAS  Google Scholar 

  29. Wu Y, Xu WW, Liu XW et al (2016) Efficacy and safety of olanzapine combined with repetitive transcranial magnetic stimulation in the treatment of behavioral and psychological symptoms of Alzheimer’s disease. Herald Med 35(10):1069–1072

    Google Scholar 

  30. Wu Y, Xu WW, Liu XW et al (2015) Effect of repetitive transcranial magnetic stimulation with different frequency on cognitive function in patients with Alzheimer’s disease. J Pratical Med 31(10):1624–1627

    Google Scholar 

  31. Ahmed MA, Darwish ES, Khedr EM et al (2012) Effects of low versus high frequencies of repetitive transcranial magnetic stimulation on cognitive function and cortical excitability in Alzheimer’s dementia. J Neurol 259(1):83–92

    Article  PubMed  Google Scholar 

  32. Paitel ER, Samii MR, Nielson KA (2021) A systematic review of cognitive event-related potentials in mild cognitive impairment and Alzheimer’s disease. Behav Brain Res 396:112904

    Article  CAS  PubMed  Google Scholar 

  33. Helfrich RF, Knight RT (2019) Cognitive neurophysiology: event-related potentials. Handb Clin Neurol 160:543–558

    Article  PubMed  Google Scholar 

  34. Jin Y, Bai X, Jiang B et al (2022) Repetitive transcranial magnetic stimulation induces quantified functional and structural changes in subcortical stroke: a combined arterial spin labeling perfusion and diffusion tensor imaging study. Front Hum Neurosci 16:829688

    Article  PubMed  PubMed Central  Google Scholar 

  35. De-Paula VJ, Radanovic M, Diniz BS et al (2012) Alzheimer’s disease. Subcell Biochem 65:329–352

    Article  CAS  PubMed  Google Scholar 

  36. Tan T, Xie J, Liu T et al (2013) Low-frequency (1 Hz) repetitive transcranial magnetic stimulation (rTMS) reverses Abeta (1–42)-mediated memory deficits in rats. Exp Gerontol 48(8):786–794

    Article  PubMed  Google Scholar 

  37. Hsu WY, Ku Y, Zanto TP et al (2015) Effects of noninvasive brain stimulation on cognitive function in healthy aging and Alzheimer’s disease: a systematic review and meta-analysis. Neurobiol Aging 36(8):2348–2359

    Article  PubMed  PubMed Central  Google Scholar 

  38. Qin Y, Zhang F, Zhang M et al (2022) Effects of repetitive transcranial magnetic stimulation combined with cognitive training on resting-state brain activity in Alzheimer’s disease. Neuroradiol J 35(5):566–572

    Article  PubMed  PubMed Central  Google Scholar 

  39. Di Lazzaro V, Bella R, Benussi A et al (2021) Diagnostic contribution and therapeutic perspectives of transcranial magnetic stimulation in dementia. Clin Neurophysiol 132(10):2568–2607

    Article  PubMed  Google Scholar 

  40. Li X, Qi G, Yu C et al (2021) Cortical plasticity is correlated with cognitive improvement in Alzheimer’s disease patients after rTMS treatment. Brain Stimul 14(3):503–510

    Article  PubMed  Google Scholar 

  41. Koch G, Casula EP, Bonni S et al (2022) Precuneus magnetic stimulation for Alzheimer’s disease: a randomized, sham-controlled trial. Brain 145(11):3776–3786

    Article  PubMed  PubMed Central  Google Scholar 

  42. Menardi A, Rossi S, Koch G et al (2022) Toward noninvasive brain stimulation 2.0 in Alzheimer’s disease. Ageing Res Rev 75:101555

    Article  CAS  PubMed  Google Scholar 

  43. Deardorff WJ, Grossberg GT (2019) Behavioral and psychological symptoms in Alzheimer’s dementia and vascular dementia. Handb Clin Neurol 165:5–32

    Article  PubMed  Google Scholar 

  44. Jiang W, Wu Z, Wen L et al (2022) The efficacy of high- or low-frequency transcranial magnetic stimulation in Alzheimer’s disease patients with behavioral and psychological symptoms of dementia. Adv Ther 39(1):286–295

    Article  PubMed  Google Scholar 

  45. Shang YQ, Xie J, Peng W et al (2018) Network-wise cerebral blood flow redistribution after 20 Hz rTMS on left dorso-lateral prefrontal cortex. Eur J Radiol 101:144–148

    Article  PubMed  Google Scholar 

  46. Nguyen JP, Suarez A, Kemoun G et al (2017) Repetitive transcranial magnetic stimulation combined with cognitive training for the treatment of Alzheimer’s disease. Neurophysiol Clin 47(1):47–53

    Article  PubMed  Google Scholar 

  47. Hiser J, Koenigs M (2018) The multifaceted role of the ventromedial prefrontal cortex in emotion, decision making, social cognition, and psychopathology. Biol Psychiatry 83(8):638–647

    Article  PubMed  Google Scholar 

  48. Jung J, Lambon RM, Jackson RL (2022) Subregions of DLPFC display graded yet distinct structural and functional connectivity. J Neurosci 42(15):3241–3252

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Li X, Du L, Sahlem GL et al (2017) Repetitive transcranial magnetic stimulation (rTMS) of the dorsolateral prefrontal cortex reduces resting-state insula activity and modulates functional connectivity of the orbitofrontal cortex in cigarette smokers. Drug Alcohol Depend 174:98–105

    Article  PubMed  PubMed Central  Google Scholar 

  50. Gamond L, Ferrari C, La Rocca S et al (2017) Dorsomedial prefrontal cortex and cerebellar contribution to in-group attitudes: a transcranial magnetic stimulation study. Eur J Neurosci 45(7):932–939

    Article  PubMed  Google Scholar 

  51. Chen Y, Cha YH, Li C et al (2019) Multimodal imaging of repetitive transcranial magnetic stimulation effect on brain network: a combined electroencephalogram and functional magnetic resonance imaging study. Brain Connect 9(4):311–321

    Article  PubMed  PubMed Central  Google Scholar 

  52. Anderkova L, Rektorova I (2014) Cognitive effects of repetitive transcranial magnetic stimulation in patients with neurodegenerative diseases-clinician’s perspective. J Neurol Sci 339(1–2):15–25

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We thank Medjaden Inc for the scientific editing of this manuscript.

Funding

This study was supported by The open subject of nursing discipline in Fujian University of Traditional Chinese Medicine in 2022 (XHL2022003).

Author information

Authors and Affiliations

Authors

Contributions

Huoqin Xiu, Fang Liu and Yufei Hou conceived the review. Huoqin Xiu and Yufei Hou wrote the manuscript. Yufei Hou, Xin Chen, and Fang Liu performed the data extraction. Huoqin Xiu, Fang Liu and Shuzhen Tu participated in the data analysis. The final version of the manuscript before submission has been approved by all authors.

Corresponding author

Correspondence to Fang Liu.

Ethics declarations

Conflict of interest

The authors declare no competing interests.

Ethical approval

None.

Statement of human and animal rights

This article does not contain any studies with animals performed by any of the authors.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Xiu, H., Liu, F., Hou, Y. et al. High-frequency repetitive transcranial magnetic stimulation (HF-rTMS) on global cognitive function of elderly in mild to moderate Alzheimer’s disease: a systematic review and meta-analysis. Neurol Sci 45, 13–25 (2024). https://doi.org/10.1007/s10072-023-07072-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-023-07072-5

Keywords

Navigation